Raluridine is a nucleoside analogue antiviral agent that functions as an inhibitor of RNA-directed DNA polymerase, primarily investigated for its potential in treating HIV infection by interfering with… Read more
Raluridine is a nucleoside analogue antiviral agent that functions as an inhibitor of RNA-directed DNA polymerase, primarily investigated for its potential in treating HIV infection by interfering with viral reverse transcription. The category includes high-quality reference standards for Raluridine API, essential for pharmaceutical research and development. Laboratories rely on these materials to perform comprehensive impurity profiling, ensuring the accurate identification and quantification of process-related impurities and degradation products that may arise during synthesis or storage. Furthermore, the inclusion of stable isotope labelled compounds facilitates advanced analytical testing, particularly in pharmacokinetic studies and bioanalysis, where they serve as internal standards for mass spectrometry. These specialized reagents support rigorous method validation and quality control procedures, allowing researchers to maintain compliance with regulatory standards throughout the drug development lifecycle.